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ABSTRACT 21 
Purpose: Reticular pseudodrusen (RPD) is a risk factor for late age-related 22 
macular degeneration (AMD). Associations between RPD and coronary artery 23 
disease (CAD) have been reported from small case-control studies. This study 24 
investigated the association of RPD within a predominantly CAD cohort. 25 
Methods: A subgroup of subjects from a multicenter randomized controlled trial 26 
of computed tomography coronary angiography (CTCA) underwent ultra-27 
widefield (UWF) retinal imaging CAD determined by CTCA was categorized as 28 
normal, non-obstructive or obstructive Specific AMD features in UWF images 29 
were graded Standardized grids were used to record the spatial location of 30 
AMD features, including RPD. Multivariate confounder adjusted regression 31 
models assessed the association between RPD and CAD. 32 
Results: The 534 participants were aged from 27-75 years (mean 58 ±9 years; 33 
425 (80%) ≥50 years) with a male preponderance (56%). Within the study 34 
sample, 178 (33%) had no CAD, 351 (66%) had CAD, 182 (34%) had 35 
hypertension and 42 (24%) had neither CAD nor hypertension. RPD was 36 
detected in 30 participants (5.6%) and bilaterally in 23. Most participants with 37 
bilateral RPD had drusen >125 µm (early AMD). After adjustment for potential 38 
confounders (age, sex, drusen >125 µm, smoking status), multivariate analysis 39 
found no significant association between CAD and RPD (odds ratio [OR] 1.31; 40 
95% Confidence Interval [CI] (0.57-3.01); p=0.52). A significant association was 41 
identified between RPD and drusen >125 µm (OR 3.18; 95% CI (1.61-6.27); p= 42 
0.001). 43 
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Conclusion: We found no evidence to support an association between CAD 44 
and RPD. RPD was strongly associated with early AMD features, when 45 
present.  46 
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INTRODUCTION 47 
Age-related macular degeneration (AMD) is the leading cause of permanent 48 
blindness in the developed world with the most sight loss occurring in the late 49 
stages, namely geographic atrophy (GA) and choroidal neovascularization (CNV).1  50 
Risk factors for progression from early to late AMD include advancing age,2 51 
cardiovascular disease (CVD),3-5 obesity,6 cigarette smoking,7 ethnicity,8 52 
hypertension,3 high cholesterol,9 genetic variants such as apolipoprotein E (ApoE) 53 
gene,10 age-related maculopathy susceptibility 2 (ARMS2) gene,11 complement 54 
factor H (CFH)12 and inflammatory markers such as C-reactive protein (CRP).13 55 
Recently, reticular pseudodrusen (RPD) have been shown to be an important 56 
independent risk factor for progression to both GA14,15 and CNV.14,16 In addition, 57 
various risk factors have been reported to be associated with RPD including 58 
advancing age, female gender, smoking, ARMS2, C3, VEGFA and CFH genetic 59 
variants.17-19 60 
 61 
The prevalence of RPD reported in the literature has varied depending on the study 62 
design, the extent to which confounding variables are accounted for, and the imaging 63 
modality used in its detection. Initial reports of the association came from data 64 
collected on AMD cohorts recruited in hospital eye clinics and reported high 65 
prevalences ranging from 29 - 52%. 17, 20-22 Data from population based studies are 66 
limited and show large variation, such as 0.4% from the Melbourne Collaborative 67 
Cohort study to 4.9% in the Rotterdam study and 13% in the Alienor study.18,19,23 68 
Such varying estimates might be attributed to the different imaging and grading 69 
protocols used.  70 
 71 
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The strong association between RPD and a thin choroid has prompted a spate of 72 
small studies that have sought associations between RPD and cardiovasccular 73 
disease.24-28 Cymerman et al reported in a small prospective cohort of patients with 74 
no known retinal disease recruited from a cardiovascular clinic; 23 participants with 75 
coronary artery disease (CAD) had a higher frequency of RPD compared to 15 who 76 
did not have CAD.24 A literature review by Rastogi and Smith25 on the association 77 
between AMD, RPD with CVD highlighted studies reporting an association between 78 
RPD and hypertension and angina.26-29 Smith and colleagues hypothesized that the 79 
increased mortality from systemic-vascular disease that affects males more severely 80 
compared to females, may account for the higher proportion of women with RPD that 81 
has been observed in various population-based studies.29  Notably this review 82 
highlighted the potential importance of large prospective cohort studies sampling 83 
participants >45 years with and without CAD to identify RPD development and 84 
potential associations.25  85 
 86 
A sub-study of the SCOT-HEART (SH) trial that incorporated ultrawide field (UWF) 87 
retinal imaging offered a unique opportunity to explore the relationship between CAD 88 
and RPD. The use of widefield technology to evaluate the retinal fundus offered an 89 
additional advantage as RPD is commonly located in the retinal arcades and beyond 90 
26 and to date there is only one study that has estimated RPD prevalence that has 91 
included central and peripheral retinal locations.30  However the sensitivity of UWF to 92 
detect RPD has not been established. We therefore first validated the methodology 93 
using images from a population based epidemiological study (the Northern Ireland 94 
Cohort of Longitudinal Ageing [NICOLA]) which captured both UWF, CFP, OCT, 95 
6 
 
infra-red and autofluorescence (AF) images of the retina and subsequently used the 96 
SH trial sub-study UWF images to explore the relationship between RPD and CAD. 97 
 98 
MATERIALS AND METHODS 99 
Validation of detection of RPD by UWF imaging 100 
Nine hundred consecutive participants were selected from the NICOLA Study. CFP 101 
was performed on the Canon CX-1 Digital Fundus Camera (Canon U.S.A., Inc., 102 
Melville, NY, U.S.A.). Stereoscopic pairs centered on the optic disc and macula were 103 
captured. CFP images were viewed and graded using the Oculab program (Digital 104 
Healthcare Oculab, V3.7.98.0, Emis Health, Leeds, UK). UWF retinal imaging was 105 
performed on the Optos Tx200 Scanning Laser Ophthalmoscope (Optos PLC, 106 
Dunfermline, UK)  using both color and AF acquisition modes. Images were viewed 107 
and graded using the Optos V2 Vantage Pro software (version 2.9.4.2). OCT images 108 
were captured using the Heidelberg Spectralis SD-OCT/SLO (Heidelberg 109 
Engineering, Heidelberg, Germany).  Images were reviewed using the Heidelberg 110 
eye explorer, HEYEX software version 1.9.10.0. Multimodal grading was undertaken 111 
with display of the multicolor enface retinal image (includes infrared reflectance, 112 
green reflectance and blue reflectance) centered on the fovea.  The grading 113 
distinguished the reticulated pattern visible on the en face images which were 114 
classified as RPD from subretinal drusenoid deposits (SDD) which are the OCT 115 
correlate seen on the high resolution OCT B scans. This distinction was made as 116 
mild and subtle features of SDD can be present before RPD are seen on the en face 117 
imaging modalities. 118 
UWF images were graded for the presence or absence of RPD by a trained single 119 
grader who was not involved in any other grading procedures with quality assurance 120 
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and review by a retina specialist (UC). Multimodal (CFP, MultiColor, AF and OCT 121 
images) grading was undertaken by trained graders in the network of UK Reading 122 
Center’s (NetwORC UK) for the presence or absence of RPD. Detection of RPD on 123 
any modality was taken as evidence of presence of this feature. Sensitivity and 124 
specificity of the UWF imaging in detecting RPD compared to the RPD detected from 125 
the NICOLA cohort’s en face images was computed. 126 
 127 
The SCOT-HEART (SH) Study and Sample 128 
The SH trial (ClinicalTrials.gov, number NCT01149590) was a multicenter 129 
randomized controlled trial undertaken in Scotland (2010-2014) on 4,146 130 
participants, aged 18-75 years, drawn from 12 cardiology clinics across Scotland.31 131 
The main aim of the study was to determine the role of multidetector computed 132 
tomorraphy in the diagnosis and management of patients attending rapid access 133 
chest pain clinics.  Participants were randomly assigned to either standard care 134 
(control intervention) or standard care and the computed tomography coronary 135 
angiography (CTCA) and calcium scores (intervention). CAD was categorized in the 136 
SH study as: (i) obstructive CAD, atherosclerotic plaque encompassing a luminal 137 
cross-sectional area of ≥70% in at least one major epicardial vessel; (ii) non-138 
obstructive CAD, either atherosclerotic plaque encompassing a luminal cross-139 
sectional area of <70% but >10% in at least one major epicardial vessel, or a 140 
calcium score >400 AU (Agatston units) or >90th percentile for age and sex; or (iii) 141 
minimal or no CAD. Non-obstructive disease was further sub-divided into mild (10-142 
50% luminal cross-sectional area) or moderate (50-70% luminal cross-sectional 143 
area) stenosis.  At two sites (Edinburgh and Dundee), consecutive patients were 144 
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approached to undergo UWF imaging immediately before or after undergoing CTCA. 145 
We assessed 534 participants from a sub-study of SH who had UWF imaging 146 
captured using two Optos P200C Scanning Laser Ophthalmoscopes (Optos PLC, 147 
Dunfermline, UK) in addition to the normal study procedures at two sites (the Clinical 148 
Research Imaging Center in Edinburgh and the Clinical Research Center Dundee).32 149 
 150 
Image Grading in SH 151 
Specific features of AMD in UWF images were graded for AMD characteristics 152 
(increased pigment, decreased pigment, drusen, maximum drusen size, reticular 153 
pseudodrusen, GA and CNV) and other peripheral abnormalities using the ‘Study-154 
specific Grading Procedures for OPERA Study,’ guidelines (November 2013).33 The 155 
Optos software utilised a modified Studies of Ocular Complications of AIDS (SOCA) 156 
optos peripheral retina AMD study (OPERA) grid (Figure 1) which was divided into 157 
three zones: Zone 1 (posterior pole), Zone 2 (extends from Z1 to a circle through the 158 
ampullae of the vortex veins) and Zone 3 (extends from Z2 to the outer periphery). 159 
The Manchester grid was superimposed on the SOCA grid to estimate the 160 
ungradable areas (Figure 2). In accordance with the OPERA guidelines, at least 50% 161 
of the subfield should be visible to grade; if < 50% of the subfield was visible, it was 162 
graded as “Cannot Grade.” If AMD characteristics and other pathologies were 163 
present in a Cannot Grade subfield, and if the grader was ≥ 90% certain the lesion 164 
was present, then grading was ascribed. Drusen presence was graded as follows: 165 
absent; questionable; 1-5 drusen; 6-20 drusen; >20 drusen or cannot grade. The 166 
maximum drusen size was graded as follows: < 125µm; ≥ 125µm, < 250µm distinct; 167 
≥ 125µm, < 250µm indistinct; ≥ 250µm distinct; ≥ 250µm indistinct or cannot grade. 168 
RPD was graded as follows: absent; questionable; < 25% of subfield; 25-49% of 169 
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subfield; 50-74% of subfield; ≥ 75% of subfield or cannot grade. RPD were defined 170 
as yellow interlacing networks ranging from 125 µm to 250 µm in width or lesions 171 
that occurred in regular well-defined domains (Figure 3). Images in which RPD were 172 
questionable were arbitrated by a retinal specialist (UC).  173 
 174 
Statistical Analysis 175 
Statistical analyses were performed using IBM SPSS Statistics version 20 176 
(Portsmouth, UK). Intraobserver agreement was calculated after 1 in 20 of the 177 
images were randomly regraded for RPD and drusen using kappa (k) statistics, 178 
which express the extent of agreement beyond chance. The interpretation of the k 179 
statistic was as follows: 0, no agreement; 0 to 0.2, slight agreement; 0.21 to 0.40, fair 180 
agreement; 0.41 to 0.60, moderate agreement; 0.61 to 0.8, substantial agreement; 181 
and >0.81, almost perfect agreement.34  182 
 183 
Univariate analysis (Chi-squared test or fisher’s exact test for categorical variables 184 
and independent t-test for continuous variables) was used to examine differences in 185 
the demographic characteristics of participants according to presence or absence of 186 
RPD. General estimating equations (GEE) which enabled data from both eyes to be 187 
included were used to examine the association between RPD and CAD while 188 
accounting for other factors identified as significant from the univariate analysis.  189 
 190 
RESULTS 191 
Validation study 192 
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UWF imaging detected 8 participants with reticular drusen (2 unilateral and 6 193 
bilateral; 100% sensitivity).. Multimodal imaging (color, multicolor, infra-red and 194 
autofluorescence) detected reticular drusen in 7 of those which were seen on en 195 
face images  The specificity of the UWF imaging was 99.9%. In one case, the UWF 196 
imaging detected RPD beyond the field of view captured by the combination of 197 
retinal imaging (Figure 4). The positive predictive value (PPV) was calculated at 198 
87.5% and the negative predictive value (NPV) was 100%.  199 
 200 
Participant Characteristics in SH study 201 
Table 1 summarizes SH study participant characteristics. In total 534 202 
individuals had UWF retinal images captured.  Two participants [4 eyes] proved 203 
difficult to scan and images were not obtained. This left 532 pairs of eyes for 204 
grading. The mean age was 58 years (range=27-75, SD 9.5) with 425 (80%) 205 
aged over 50 years. There were 299 males (56%). 178 (33%) had no CAD, 351 206 
(66%) had CAD present, whilst 182 (34%) had hypertension and 42 (24%) had 207 
no CAD or hypertension. 208 
 209 
Intragrader agreement in SH study 210 
The intragrader agreement illustrated in Table 2 gives the kappa range for the AMD 211 
features, the presence of RPD ranged from: 0.62-0.76, drusen: 0.58-0.64, maximum 212 
drusen size: 0.55-0.62, increased pigment: 0.54-0.61, decreased pigment: 0.55-0.62, 213 
GA: 0.62-0.76, neovascular AMD: 0.57-0.66 and peripheral abnormality: 0.55-0.59 214 
within zones 1-3. For the lesions which were absent in the cohort the discordance in 215 
the grading originated from a change of grade of feature absent to ungradeable 216 
between the two gradings. 217 
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 218 
Prevalence of RPD and AMD features in the SH study 219 
RPD was present in one or both eyes of 30 participants (5.6%) and bilateral in 23 220 
participants (4.3%). Drusen >125μm were present in 201 participants (38%).  221 
Participants with RPD ranged in age from 33-75 years (mean 59) and there were 222 
equal numbers of males and females. The other AMD features graded as present in 223 
the participants were as follows: 352 (66%) had hyperpigmentation, 55 (10%) had 224 
hypopigmentation, 2 (0.4%) had unilateral GA, none of the participant was classified 225 
as having neovascular AMD and 183 (34%) showed other non-AMD peripheral 226 
abnormalities.  227 
 228 
Association of CAD with RPD 229 
CAD was present in 20 participants and absent in 10 participants with RPD, 230 
however, no statistically significant association between RPD and CAD was found on 231 
either the unadjusted or adjusted generalized estimating equations (GEE) model 232 
(p>0.05, Table 3). With respect to associations between RPD and other early AMD 233 
features a strong association was noted with drusen >125μm in the fully adjusted 234 
model. Eighteen participants had both RPD and drusen >125μm, while 11 235 
participants had RPD alone without evidence of soft drusen.   236 
 237 
DISCUSSION 238 
This is the first study to report the prevalence of RPD from a cohort drawn from a 239 
cardiovascular clinical setting which had also captured UWF retinal images thus 240 
allowing  an examination of potential associations . Contrary to previous reports, we 241 
failed to find a significant association between RPD and the presence of 242 
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anatomically defined CAD.24-27,29  Our findings are in accordance with population 243 
based studies and some of the clinical cohorts that did not report significant 244 
associations between RPD and CAD or hypertension.17-19,21-23  In fact, the 245 
prevalence of RPD observed in the current study (30 out of 534 participants - 5.6%) 246 
is similar to that reported by the population based Rotterdam study (4.9%),18 247 
providing additional support for the view that CAD is not associated with an 248 
increased prevalence of RPD.   249 
 250 
While 80% of participants were aged over 50, a common age restriction for many 251 
AMD studies, interestingly 8 participants with RPD were aged under 50, the 252 
youngest aged 33. Of these 4 (50%) also had evidence of drusen >125μm whereas 253 
the rest had no other features of AMD present. In the overall sample, 7 participants 254 
had RPD without any other AMD features similar to previous observations,18 which 255 
may reflect a different phenotype given that RPD have been reported in other retinal 256 
diseases such as Sorsby fundus dystrophy, pseudoxanthoma elasticum and 257 
acquired vitelliform lesions.35-37 Given the rarity of these participants, it is likely that 258 
studies of large sample size or pooled analyses across studies will be required to 259 
improve our understanding of the relevance of these isolated RPD.  260 
 261 
This is also the second study, to our knowledge, that used UWF imaging for the 262 
evaluation of RPD.30 The validation protocols implemented using NICOLA image 263 
data confirmed the reliability of this approach to detect the reticular pattern that has 264 
been observed when using other en face modalities such as IR or AF imaging. 265 
Nonetheless we are of the view that as with other en face modalities color UWF also 266 
underestimates the prevalence because the earliest stages of this phenotype of SDD 267 
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is best appreciated on high resolution SD OCT.38  Stage one SDD is defined by the 268 
dispersed nature of the deposits of granular hyperreflective material  that is present 269 
in the outer retina in the region of the photoreceptors’ inner and outer segments (the 270 
IS/OS boundary) and the retinal pigment epithelium, prior to the characteristic 271 
reticulated pattern that accompanies stages 2 and 3, which have been attributed to 272 
focal deposits that cause marked alterations to the IS/OS boundary and thus 273 
become detectable by en face imaging.38 Currently it is accepted that detection of 274 
RPD is best when a multimodal approach, combining infra-red reflectance, AF and 275 
SD-OCT are used.23,39 We were however reassured by the validation study which 276 
demonstrated the benefit of the increased field of view provided by UWF imaging 277 
and that RPD was evident in at least one participant in the retinal fundus in an area 278 
that is typically not evaluated in AMD studies using CFP (35° or 45°), raising the 279 
possibility of under ascertainment when the evaluated images are restricted to the 280 
central fundus. 281 
 282 
A potential limitation of this study is the choice of controls and the few RPD cases, 283 
as all recruits were attending the cardiology clinic for suspected angina. However the 284 
trial participants were recruited from a Chest pain clinic, and they were subsequently 285 
classified as having no CAD on the basis of clinical examination, computed 286 
tomography coronary angiography and calcium scores. Whether this cohort is 287 
representative of what may be observed in a random population based sample is 288 
unclear. Even though we adjusted for age, sex and the presence of smoking, given 289 
the focus of the SH trial, some of the traditional AMD risk factors, such as diet and 290 
known genetic risk variants, were not available and therefore residual confounding 291 
may be present.  292 
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 293 
In conclusion, our study does not support previously reported associations with CAD, 294 
yet the strong association observed with other AMD features in this non-AMD cohort 295 
highlights the necessity for improved understanding of the mechanisms and 296 
ethiology of this intriguing phenotype.  To do so, more data from large and well 297 
characterized longitudinal population based studies with multimodal imaging will be 298 
required. addition, pooled analyses of multiple studies to improve statistical power 299 
may help untangle the complexity of the risk factors and sub-phenotypes involved.   300 
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 429 
 430 
Figure 1: The Modified SOCA Grid utilized on the Optos Software. 431 
Z1 and Z2 are each divided into four quadrants: superonasal (SN), superotemporal 432 
(ST), inferotemporal (IT), and inferonasal (IN). Z3 is divided into two hemispheres 433 
(superior, inferior) using a visual extension of the horizontal cross line (yellow 434 
dashed lines). Taken from the Study-Specific Grading Procedures for OPERA, 435 
University of Wisconsin (2013).33  436 
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 437 
Figure 2: Optos ultra-widefield retinal image grading grids for specific AMD 438 
characteristics.  439 
The SOCA grid is divided into three zones: Zone 1 (posterior pole), Zone 2 (extends 440 
from Z1 to a circle through the ampullae of the vortex veins) and Zone 3 (extends 441 
from Z2 to the outer periphery). The Manchester grid was superimposed onto the 442 
SOCA grid to assess the ungradable areas. 443 
  444 
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 445 
 446 
Figure 3: Optos ultra-widefield retinal image illustrating RPD. 447 
RPD is a subtype of AMD associated with subretinal drusenoid deposits located 448 
between the retinal pigment epithelium and the inner ellipsoid zone. 449 
  450 
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 451 
Figure 4 shows the RPD interlacing pattern on both the UWF and fundus camera 452 
image. A. UWF pseudo color image showing RPD (black circle). B. UWF green laser 453 
imaging with RPD visible within the black circle. C. Fundus camera image with RPD 454 
within the black circle. D. UWF pseudo color image with arrows pointing to areas of 455 
RPD. E. UWF green laser imaging with arrows annotating areas of RPD. In this case 456 
RPD was detected beyond the field of view of color fundus photography. F. 457 
25 
 
Corresponding fundus camera image with no readily visible RPD within the black 458 
circle.   459 
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Table 1. Summary statistics for study participants. 460 
 461 
   
 
All 
participants
N=534 
Reticular Pseudodrusen (1 or 
both eyes) 
 
Absent 
N=504 
 
Present 
N=30) 
 
 
P 
Age 
Mean (SD) 
 
58 (10) 
 
58 (9) 
 
59 (12) 
 
0.76 
Sex (%) 
Male 
Female 
 
299 (56) 
235 (44) 
 
284 (56) 
220 (44) 
 
15 (50) 
15 (50) 
 
 
0.57 
BMI 
Mean (SD) 
 
30 (7) 
 
30 (7) 
 
28 (6) 
 
0.19 
CAD diagnosis (%) 
None 
Non-Obstructive-Mild 
Non-Obstructive-Moderate 
Obstructive CAD 
Missing  
 
178 (33) 
114 (21) 
87 (16) 
150 (28) 
5 (1) 
 
168 (33) 
105 (21) 
84 (17) 
142 (28) 
5(1) 
 
10 (33) 
9 (30) 
3 (10) 
8 (27) 
0 (0) 
 
 
 
 
 
0.71 
CAD (%) 
Absent 
Present 
Missing 
 
178 (33) 
351 (66) 
5 (1) 
 
168 (33) 
331 (66) 
5 (1) 
 
10 (33) 
20 (67) 
0 (0) 
 
 
 
0.99 
Assign Score 
Mean (SD) 
 
18 (12) 
 
18 (12) 
 
17 (11) 
 
0.56 
Coronary Artery Calcium 
Score 
Mean (SD) 
 
314 (805) 
 
310 (814) 
 
376 (634) 
 
0.67 
Hypertension (%) 
No  
Yes 
Missing 
 
346 (65) 
182 (34) 
6 (1) 
 
327 (65) 
171 (34) 
6 (1) 
 
19 (63) 
11 (37) 
0 (0) 
 
 
 
0.84 
Diabetes (Type1 or 2) (%) 
No  
Yes 
 
483 (90) 
51 (10) 
 
455 (90) 
49 (10) 
 
28 (93) 
2 (7) 
 
 
0.76 
Drusen >125μm (%) 
Absent 
Present 
Missing 
 
330 (62) 
201 (38) 
3 (1) 
 
319 (63) 
183 (36) 
2 (1) 
 
11 (37) 
18 (60) 
1 (3) 
 
 
 
0.01 
Smoking History (%) 
Never 
Ex-smoker 
Current Smoker 
 
256 (48) 
193 (36) 
85 (16) 
 
244 (48) 
183 (36) 
77 (15) 
 
12 (40) 
10 (33) 
8 (27) 
 
 
 
0.25 
 462 
  463 
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Table 2.  Intragrader agreement for the individual age-related macular 464 
degeneration phenotypes. 465 
AMD Characteristic Kappa Range 
Zone 1        Zone 2        Zone 3 
Neovascular AMD 0.66      0.57 0.61 
Increased Pigment 0.59    0.54 0.61 
Decreased Pigment 0.66 0.55 0.62 
Geographic Atrophy 0.66 0.76 0.62 
Drusen 0.59 0.64 0.58 
Maximum Drusen Size 0.60 0.62 0.55 
Reticular Pseudodrusen 0.67 0.76 0.62 
Peripheral Abnormality N/A 0.59 0.55 
Presence of other Pathology (All zones) 0.62 
 466 
  467 
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Table 3 – Investigation of coronary artery disease as a risk factor for reticular 468 
pseudodrusen using generalized estimating equations. 469 
 470 
 Unadjusted model Age and Sex adjusted Multivariate adjusted* 
 OR 95% CI P OR 95% CI P OR 95% CI P 
CAD 1.30 0.58-2.92 0.52 1.33 0.57-3.11 0.52 1.31 0.57-3.01 0.52 
Age    1.01 0.95-1.07 0.78 1.00 0.95-1.06 0.92 
Sex    1.51 0.67-3.40 0.32 1.40 0.62-3.14 0.42 
Drusen 
>125 μm 
      3.18 1.61-6.27 0.001 
 471 
*Multivariate model was adjusted for age, sex and smoking status. 472 
 473 
